ANAB — AnaptysBio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for AnaptysBio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	374	394	548	441	391
Net Total Receivables	0	—	0.876	1.42	6.85
Prepaid Expenses
Total Current Assets	378	397	554	447	407
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.02	2.13	21.8	20	18.3
Long Term Investments
Other Long Term Assets
Total Assets	435	417	643	610	452
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	29.5	19.8	16.1	26.1	37.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	30.2	19.8	287	348	364
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	405	397	356	262	88.1
Total Liabilities & Shareholders' Equity	435	417	643	610	452
Total Common Shares Outstanding